Cite
HARVARD Citation
McDonald, C. et al. (2022). Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 399 (10329), pp. 1049-1058. [Online].